Suppr超能文献

舌下含服舒芬太尼治疗术后疼痛的药代动力学和药效学评价

Pharmacokinetic and pharmacodynamic evaluation of sublingual sufentanil in the treatment of post-operative pain.

作者信息

Babazade Rovnat, Turan Alparslan

机构信息

a Department of Outcomes Research , Cleveland Clinic , Cleveland , OH , USA.

出版信息

Expert Opin Drug Metab Toxicol. 2016;12(2):217-24. doi: 10.1517/17425255.2016.1134487. Epub 2016 Jan 22.

Abstract

INTRODUCTION

Intravenous patient-controlled analgesia using opioids is frequently used to provide perioperative analgesia. However, there are a number of drawbacks for intravenous patient-controlled analgesia. The sufentanil sublingual tablet system is a major evolution in technology and drug development for postoperative pain management.

AREAS COVERED

We reviewed the use of sublingual sufentanil in postoperative pain management, with a focus on chemistry, pharmacokinetics and clinical use in different surgical patients.

EXPERT OPINION

The sufentanil sublingual tablet system can decrease intravenous patient-controlled analgesia-related safety issues. Current clinical studies have demonstrated this novel system to be safe and effective in postoperative pain management.

摘要

引言

使用阿片类药物的静脉自控镇痛常用于提供围手术期镇痛。然而,静脉自控镇痛存在诸多缺点。舒芬太尼舌下片系统是术后疼痛管理技术和药物研发的一项重大进展。

涵盖领域

我们回顾了舌下舒芬太尼在术后疼痛管理中的应用,重点关注其化学性质、药代动力学以及在不同手术患者中的临床应用。

专家观点

舒芬太尼舌下片系统可减少与静脉自控镇痛相关的安全问题。目前的临床研究已证明这一新型系统在术后疼痛管理中安全有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验